Biologicals
- LIU X, Zha Y, Wang Z, Jiang Y, et al
The pharmacokinetics and safety comparison of Zamerovimab and Mazorelvimab
monoclonal antibodies vs. HRIG in category III rabies post-exposure prophylaxis:
a stratified analysis by wound characteristics.
Biologicals. 2025;92:101852.
J Sch Health
- LAORUJISAWAT M, Nakpan W, Prasertchai A, Thammakun T, et al
Strengthening Rabies Protection Behaviors Among Thai Children: The Role of Health
Literacy and Protection Motivation.
J Sch Health. 2025 Aug 11. doi: 10.1111/josh.70059.
Lancet
- KULKARNI PS, Potey AV, Kapse D, Bhamare C, et al
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in
category 3 potential exposure patients: a phase 4, open-label, randomised,
active-controlled trial.
Lancet. 2025;406:627-635.
- GEURTSVANKESSEL CH, Visser LG
Efficacy and safety of monoclonal antibody PEP for rabies.
Lancet. 2025;406:578-579.
Med Leg J
- PHULWARE RH, Dhiman A, Sindhu Y, Meshram RP, et al
Postmortem diagnosis of human rabies viral encephalitis: Insights into
pathogenesis through the vigilant lens of the forensic pathologist!
Med Leg J. 2025 Aug 9:258172251328963. doi: 10.1177/00258172251328963.
Mil Med
- PARK DH, Kim SY, Seong G, Oh HS, et al
A Clinical Analysis of Rabies Post-Exposure Prophylaxis After Animal Bite Cases
in the Republic of Korea Armed Forces.
Mil Med. 2025 Aug 6:usaf364. doi: 10.1093.
PLoS Negl Trop Dis
- BOR N, Njenga G, Slater A, Munywoki P, et al
Rabies control via co-creation: A model for sustainable one health interventions.
PLoS Negl Trop Dis. 2025;19:e0013350.
Prev Vet Med
- PEREIRA AJ, Ximenes D, Joao AADC, Gomes MB, et al
An assessment of knowledge, attitudes, and practices concerning rabies among
communities with a high disease risk in Timor-Leste.
Prev Vet Med. 2025;244:106653.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016